Itaconix (ITX) H2 2024 earnings summary

Executive summary

• Achieved $6.5 million in 2024 revenue, down 17% year-over-year due to exiting a low-margin merchandiser, but core business grew 55%.

• Second half 2024 revenue of $3.7 million was among the highest half-year results, providing strong momentum into 2025.

• Diversified customer base: no single customer accounted for more than 20% of revenue in 2024, compared to 80% concentration in 2023.

• Focused on high-value, high-demand products, postponing those with only sustainability benefits and limited customer demand.

• Expanded product line to 17 products across four functional areas, with continued innovation and new launches.

Financial highlights

• Gross profit margin improved from 31% to 34.7% in 2024, despite lower revenue.

• Gross profit dollars remained stable year-over-year due to margin improvement.

• Increased working capital by $1 million to support European growth.

• Fixed asset turnover ratio reached 11x, over 5x higher than industry peers.

• Intangible assets include 16 patent families and GBP 200,000 in capitalized development.

Outlook and guidance

• Entering 2025 with strong revenue momentum and in line with market expectations.

• Not expecting breakeven profitability in 2025, but losses are projected to decrease significantly.

• Continued focus on margin improvement, customer diversification, and plant utilization.

• No significant revenue expected from superabsorbents in 2025 or 2026; focus remains on scale inhibition and odor control.

• European market expected to continue as a key growth driver.